Radiopharmaceutical Support

Bracken’s radiopharmaceutical team leverages our collective wisdom and years of experience within industry and clinical execution, including clinical development and commercial strategy, commercial due diligence, and market launches.

As a leading, concierge-style life sciences consultancy, Bracken provides our clients with customized strategic and operational solutions that address a broad range of opportunities and challenges. Members of our team have both commercialized and been directly involved in clinical trials with diagnostic probes, imaging biomarkers, and systemic radiation therapy/theranostic indications. Combined, Bracken’s consultants have also authored or co-authored 100+ publications in radiopharmaceuticals.

Bracken’s global team is driven by passion, innovation, and unity.

Our diverse group of professionals provide insights and support on a C-Suite or ad hoc basis in the radiopharmaceutical arena, helping to grow your team, product, services, and/or concept. We also “roll our sleeves up” and manage and support the operational aspects of your project.

From physicians and scientists to entrepreneurs and drug development leaders, our team brings an unrivaled depth of knowledge and skill to radiopharmaceutical support.

Our executive consultants handle business scenarios for a broad and diverse group of clients, from startups to Fortune 500, on radiopharmaceutical projects including clinical development strategy and support, regulatory affairs, due diligence, commercialization strategy and product launches, clinical trial strategy, and beyond.

Clinical Development

• Clinical development strategy.
• Precise clinical execution in the radiopharmaceutical industry, including alpha and beta emitters for systemic radiation therapy (SRT) and theranostics.
• Diagnostic and therapeutic radiopharmaceuticals.
• Running clinical trials with diagnostic probes, biomarkers and theranostic indications.
  
• Supporting and managing radiopharmaceutical laboratories and byproducts.
• Regulatory Affairs support in the radiopharmaceutical market, including FDA communications and meetings, NDAs, and a detailed understanding of CMC
  
• Translational science of radiopharmaceuticals in clinical trials.
• Our consultants are regularly asked to serve as fractional CMOs, CSOs, CFOs, CCOs, COOs, or Heads of Regulatory.
  

Commercialization

• Commercial strategy development and market launches.
• Commercial due diligence, market validation, and competitive analysis.
• Medical Affairs support.
• Market Access support.
• Radiopharmaceutical supply chain, logistics, and risk mitigation.